EP3897672
Samsett HBV-meðferð
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
19.12.2019EP published:
9.8.2023EP application number:
19842679.3
EP translation filed:
30.10.2023Grant published:
15.12.2023EPO information:
European Patent Register
Max expiry date:
18.12.2039Expiry date:
18.12.2026Next due date:
31.12.2026
Title in English:
COMBINATION HBV THERAPYLanguage of the patent:
English
Timeline
Today
19.12.2019EP application
9.8.2023EP Publication
30.10.2023Translation submitted
15.12.2023Registration published
18.12.2026Expires
Owner
Name:
VIR Biotechnology, Inc.Address:
1800 Owens Street, Suite 900, San Francisco, CA 94158, US
Name:
Humabs Biomed SAAddress:
Via dei Gaggini, 3, 6500 Bellinzona, CH
Inventor
Name:
BAKARDJIEV, AnnaAddress:
San Francisco, California 94158, US
Name:
PANG, Phillip S.Address:
San Francisco, California 94158, US
Name:
CORTI, DavideAddress:
6500 Bellinzona, CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201862782896 PDate:
20.12.2018Country:
US
Classification
Categories:
A61K 31/713, A61P 31/20, A61K 39/42
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 15.12.2023
Expires: 18.12.2024
Payer: Árnason Faktor ehf.
Number: 6
Paid: 10.12.2024
Expires: 18.12.2025
Payer: Árnason Faktor ehf.
Number: 7
Paid: 15.12.2025
Expires: 18.12.2026
Payer: Árnason Faktor ehf.